Zai Lab Limited operates as a biopharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.

Next Day Disclosure Return

Announcements and Notices - [Share Scheme]

Grant Of Restricted Shares

Announcements and Notices - [Results of AGM / Share Scheme]

Voting Results Of Annual General Meeting

Announcements and Notices - [Overseas Regulatory Announcement - Corporate Governance Related Matters]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Zai Lab (9688 HK)

Next Day Disclosure Return

Next Day Disclosure Return

Grant Of Restricted Shares

Voting Results Of Annual General Meeting

Overseas Regulatory Announcement - Form 8-K

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)